Research Articles
Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.
Article Title | Original Publication Date | Journal | Bone Marrow Disease |
---|---|---|---|
Imetelstat Achieves Meaningful and Durable Transfusion Independence in High Transfusion-Burden Patients With Lower-Risk Myelodysplastic Syndromes in a Phase II Study | Jan 2021 | Journal of clinical oncology: official journal of the American Society Clinical Oncology | Myelodysplastic Syndromes (MDS) |
Current and emerging strategies for management of myelodysplastic syndromes | Dec 2020 | Blood reviews | Myelodysplastic Syndromes (MDS) |
Validation of International Working Group response criteria in higher-risk myelodysplastic syndromes: A report on behalf of the MDS Clinical Research Consortium | Dec 2020 | Cancer Medicine | Myelodysplastic Syndromes (MDS) |
Survival following relapse after allogeneic hematopoietic cell transplantation for acute leukemia and myelodysplastic syndromes | Dec 2020 | Hematology/oncology and stem cell therapy | Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS) |
Patient stratification in myelodysplastic syndromes: how a puzzle may become a map | Dec 2020 | Hematology. American Society of Hematology. Education Program | Myelodysplastic Syndromes (MDS) |
Parsing the Paradox of Myelodysplastic Syndromes | Dec 2020 | Journal of clinical oncology: official journal of the American Society Clinical Oncologysd | Myelodysplastic Syndromes (MDS) |
Outpatient transfusions for myelodysplastic syndromes | Dec 2020 | Hematology. American Society of Hematology. Education Program | Myelodysplastic Syndromes (MDS) |
Therapy for lower-risk MDS | Dec 2020 | Hematology. American Society of Hematology. Education Program | Myelodysplastic Syndromes (MDS) |
Existing agents, novel agents, or transplantation for high-risk MDS | Dec 2020 | Hematology. American Society of Hematology. Education Program | Myelodysplastic Syndromes (MDS) |
Randomized trials with checkpoint inhibitors in acute myeloid leukaemia and myelodysplastic syndromes: What have we learned so far and where are we heading? | Dec 2020 | Best practice & research. Clinical haematology | Myelodysplastic Syndromes (MDS) |